Mirion Technologies Appoints Michael Rossi as President of Mirion Medical – Imaging Technology News
October 7, 2022 — Mirion Technologies, Inc., a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the appointment of Michael Rossi as the President of Mirion Medical. Michael will report directly to Mirion’s CEO, Tom Logan, who had been acting as President of the business segment.
Michael joins Mirion from Novartis, where he most recently served as the Head of Radioligand Imaging for the Advanced Accelerator Applications business. Prior to Novartis, Michael spent five years at Jubilant Pharma where he served in several different roles with increasing levels of responsibility. Michael also brings experience from GE Healthcare, Tyco Healthcare/Mallinckrodt and Syncor International to the Mirion team. Michael earned a Bachelor of Science in Pharmacy degree from the University of the Sciences – Philadelphia College of Pharmacy and carries the Authorized Nuclear Pharmacist Certification from Butler University. Michael has also served on several Boards of Directors and remains a Licensed Pharmacist in the state of Pennsylvania.
“I am thrilled to welcome Michael to the Mirion team,” said Tom Logan, Mirion’s CEO. “Michael has a unique blend of domain experience and leadership qualities in the nuclear medicine space. His appointment comes at an exciting time for the Company, as we aim to drive organic and inorganic growth and margin expansion across our medical business. I am confident that Michael will accelerate the attainment of our healthcare ambitions.”
“I am incredibly excited to be joining Mirion Medical at such an impactful time in the Company’s growth trajectory,” added Michael Rossi. “What Tom and the team have built over the last few years is truly impressive and I look forward to building off the solid momentum with my new colleagues.”
For more information: www.ir.mirion.com
October 6, 2022 ‑— Ahead of the 64th Annual Meeting of the American Society for Radiation Oncology (ASTRO), set for …
October 6, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology and the …
Here is a recap of what ITN viewers found most interesting during the month of September: 1. Lasting Lung Damage Seen in …
The 64th Annual Meeting of the American Society for Radiation Oncology (ASTRO) will take place October 23-26, at the …
September 29, 2022 — Radformation Inc and Videra Surgical are pleased to announce a collaboration integrating Videra …
September 28, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and …
September 28, 2022 — Xoran Technologies is engaged in a ground-breaking research project to develop a PET/CT scanner for …
September 26, 2022 — Cleveland Clinic received a $7.9 million five-year grant from the National Cancer Institute at the …
September 22, 2022 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and …
The theme “Everyday progress” seems appropriate for the imaging community in 2022. What a year it’s been. Supply …
See All Webinars
See All Videos
See All Blogs
See All Comparison Charts